AACR Hematologic Malignancies Research Fellowship
Two year grant of $130,000 for a postdoctoral or clinical research fellow to conduct research projects focused on hematologic malignancies.
Related Articles
Glofitamab Produces Durable Remissions in R/R Mantle Cell Lymphoma
Glofitamab generated high response rates and durable remissions in R/R mantle cell lymphoma, including high-risk subgroups, with sustained MRD negativity.
Integrating cancer into crisis: a global vision for action from WHO and partners
More than a billion people live in fragile, conflict-affected, and vulnerable settings requiring humanitarian support, where cancer is a substantial health issue. Despite its substantial…
Blocking a cancer escape hatch
Fred Hutch graduate student Adam Nguyen has won a F31 training award from the NIH to study a complex molecule called Tie2 that aids and…
Registration
Prices are based on membership status. Once logged in, the correct registration rate will automatically populate. Physician, Scientist, Industry (Non-Exhibitor), PhD, Other $749 Resident/Student, Fellow,…
Glofitamab Produces Durable Remissions in R/R Mantle Cell Lymphoma
Glofitamab generated high response rates and durable remissions in R/R mantle cell lymphoma, including high-risk subgroups, with sustained MRD negativity.
Integrating cancer into crisis: a global vision for action from WHO and partners
More than a billion people live in fragile, conflict-affected, and vulnerable settings requiring humanitarian support, where cancer is a substantial health issue. Despite its substantial…
The addition of inotuzumab ozogamicin to conditioning for alloSCT in ALL and lymphoid malignancies
Issa Khouri, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses a study investigating the addition of inotuzumab ozogamicin to a reduced-intensity…
Ultra-Sensitive Duplex Sequencing Improves Diagnostic Capabilities in Indolent Systemic Mastocytosis
Tracy I. George, MD, discusses how ultra-sensitive duplex sequencing expands diagnostic capabilities in ISM by improving the detection of KIT mutations.
Unprecedented Advances and Persistent Challenges: Key Insights from AACR’s 2024 Cancer Progress Reports
AACR’s 2024 Cancer Progress Report and Cancer Disparities Progress Report shared insights into advances and challenges in cancer research.